Dr Jason Westin presenting excellent CAR T cell overview ⁦ASCO⁩ FDA Approval and clinical Impact #ASCO21 Ed session.

Join women oncology professionals and supporter or women in oncology during #ASCO21 for this inspiring virtual session- support Women Who Conquer Cancer- YIA and CDAs Conquer Cancer, the ASCO Foundation to find. The next cures. Toll we meet in person again at #ASCO22

Deanna van Gestel leads Vaniam group-intros annual Women Leaders in Oncology at #ASCO21. 8th women’s event has raised >$400k for YIAs for ⁦Conquer Cancer, the ASCO Foundation⁩ Tonight’s challenge: ‘22 YIA $57,500 & start Endowed YIA $1.35 mil with Vaniam matching to $100K! Text WLO to 41444 !

Inspiring ⁦Conquer Cancer, the ASCO Foundation⁩ Women Who Conquer CA leader -Dr Swain shows >$5mil raised/8 Yrs for CDAs, YIAs, endowed YIAs & women mentor awards. US and Int’l women, two CDAs and 8 YIAs this year is another milestone- donate to support scientists who will find next cures.

Inspired by @COH colleagues honoring Dr Warren Chow’s 31 year career of cutting edge science, and patient care with kindness and a zest for life. We wish him continued success at UCI where he will remain our friend & colleague. Dr. Ravi Salgia Sumanta K. Pal, MD, FASCO Erminia Massarelli Joseph Chao

On behalf of special editors, @NarjustDumaMD , Miguel Villalona Calero, MD , gilberto lopes, Pelin Cinar & me, we challenge colleagues to PICK an AREA to improve: access, engagement, care, trials & workforce informed by JCO Oncology Practice special issue authors.

Grateful to experts who spent the past year building JCO Oncology Practice special issue - sharing work of experts that can be used to reduce disparities in access, care, engagement, workforce and trials for Hispanic/LatinX in US. @NarjustDumaMD Ana I. Velázquez Mañana, MD, MSc, FASCO Gladys Rodriguez,MD, FASCO Miguel Villalona Calero, MD

Strongly encourage a vote for Dr. Monty Pal for ASCO nominating committee. He is a true mentor who values and encourages diverse voices and ideas, a visionary researcher and gifted clinician who can bring insights to ASCO to further the mission and vision.

Setting new trend for comfy (OnCloud) footwear for the ASCO meeting starting today! Off to learn with ‘corrected badge’ as MD+PhD2B - with dissertation moving toward completion but didn’t get done and defended before ASCO’23. Love learning! See you all soon.

For the trials presented at #asco23 and other major meetings, it’s ok to think for yourself ans ask whether the trial was really well done, rather than just join the crowd. Also BTW, the reason we have “Discussion” after every talk is to ask critical questions.

We should be requiring summaries of results in all presentation that are for patients- how many per 100 who take the therapy benefit in what ways va standard and how many per 100 have specific side effects. Reporting % improvement vs standard or placebo is not patient centric.

Sincere congratulations to JCO GO editors, reviewers and contributors for this outstanding 4.5 IF achievement! Content that is relevant, reviewed and informative. Kudos team!

Such a well deserved honor for Dr Taparra’s pioneering work in NHPI health care disparities to be recognized and him be chosen with select others for the Obama Foundation USA Leaders program. Made my day to see the notice and anticipate more breakthrough work from Dr T!